ºÚÁϸ£ÀûÍø

Ashley’s research focuses on applying engineering technologies to create sophisticated in vitro tissue and organ models for drug testing and disease modelling purposes. He has led projects concerning microfluidic gradient culture systems for adipose tissue vascularisation, scaffolds for supporting 3D neural cell network formation, collagen biomaterials for retinal models, and microbioreactors for monitoring blood stem cell behaviour. Ashley has a diverse and multidisciplinary research background spanning fields of stem cell biology, biomaterials fabrication, device engineering, tissue engineering, organoids and AI-supported image analysis.

Ashley is currently focused on developing microbioreactor technologies towards cost-effective hematopoietic stem cell production. The manufacture of cell therapies remains prohibitively expensive and new cost-effective production methods are therefore required to ensure future affordability and accessibility. To address this, Ashley is exploring innovative hydrogel scaffolds and bio-inspired perfusion bioreactor technologies.

Dr Ashley Murphy is a Marie SkÅ‚odowska-Curie Actions postdoctoral fellow at the Eindhoven University of Technology (ºÚÁϸ£ÀûÍø) department of Biomedical Engineering. Ashley holds bachelor’s degrees in engineering (honours I) and pharmaceutical science from Monash University (Australia, 2015). He completed a PhD in engineering at Monash University (2018) under the primary supervision of Professor Neil Cameron. Ashley joined the Commonwealth Scientific and Industrial Research Organisation (CSIRO, Australia) as a CSIRO Early Career (CERC) Research Fellow (2019 – 2021). He then completed postdoctoral appointments at the University of Queensland (2022 – 2023, Australia) and MERLN Institute, Maastricht University (2024 – 2025, Netherlands). In 2024 Ashley was awarded a Marie SkÅ‚odowska-Curie Actions postdoctoral fellowship and subsequently commenced at ºÚÁϸ£ÀûÍø under the supervision of Sandra Hofmann and Miguel Castilho in 2025.